Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Community Service – Defining Moment

Apr 29, 2019/Podcast

Sylvestra Ramirez, PT, DPT, discusses creating a clinic that literally speaks its patients’ language.

The Women Who Shaped Our Lives

Mar 16, 2022/Perspective

We asked seven APTA members about the women who inspired them in their chosen profession, and how they in turn hope to impact the future of physical therapy. Here's what they had to say.

Surgery Offers No Advantages in Treatment of Achilles' Ruptures

Apr 19, 2022/Review

A study found that both open-repair and minimally invasive procedures resulted in outcomes similar to nonsurgical treatment.

Yes, You Can: How to Invest in Your Career While Paying Down Debt

Apr 13, 2022/Perspective

Paying off debt doesn't have to mean putting career advancement on hold.

Proposed FY '23 IRF Rule: 2% Increase, Cap on Wage Index Cut, Calls for Input

Apr 5, 2022/Review

Similar to the 2022 rule, CMS keeps changes minimal in response to pandemic-related disruptions.

The Good Stuff: Members and the Profession in the Media, March 2022

Mar 16, 2022/Roundup

This month's Good Stuff: Members on everything from working with the U.S. Olympic ski team to the ways physical activity can slow age-related cognitive decline, and more.

Support for Workforce Diversity, Research on SDOH Solutions Part of New Bill

Mar 18, 2022/News

The APTA-backed federal legislation would provide scholarships and stipends to increase diversity in physical therapy education programs.

PTAs: Advanced Proficiency Pathways Enrollment Deadline May 31

Apr 15, 2022/News

Prioritize your career development and enrich your knowledge in a specific area of care through APTA’s innovative program.

The Nuances of Working With Commercial Payers

Mar 1, 2023/Feature

It's about speaking up in the right ways to the right people at the right time.

More Physical Activity Linked to Better COVID-19 Outcomes

Jan 13, 2023/Review

Authors found a dose-response relationship between PA and adverse COVID-19 events that was consistent across multiple subgroups.